165 related articles for article (PubMed ID: 30354399)
41. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
Weiner RB; Baggish AL; Chen-Tournoux A; Marshall JE; Gaggin HK; Bhardwaj A; Mohammed AA; Rehman SU; Barajas L; Barajas J; Gregory SA; Moore SA; Semigran MJ; Januzzi JL
Eur J Heart Fail; 2013 Mar; 15(3):342-51. PubMed ID: 23132825
[TBL] [Abstract][Full Text] [Related]
42. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
43. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.
Jaubert MP; Armero S; Bonello L; Nicoud A; Sbragia P; Paganelli F; Arques S
Arch Cardiovasc Dis; 2010 Jan; 103(1):3-9. PubMed ID: 20142114
[TBL] [Abstract][Full Text] [Related]
44. The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The "Hemodynamic Recovery".
Romano G; Vitale G; Ajello L; Agnese V; Bellavia D; Caccamo G; Corrado E; Di Gesaro G; Falletta C; La Franca E; Minà C; Storniolo SA; Sarullo FM; Clemenza F
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817815
[TBL] [Abstract][Full Text] [Related]
45. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
[TBL] [Abstract][Full Text] [Related]
46. Management of patients with chronic heart failure and type 2 diabetes mellitus: the SCODIAC-II study.
De Luca M; Bosso G; Valvano A; Guardasole V; Botta A; Carbone V; Carella G; Del Buono A; Di Giovanni G; Fimiani B; Guarnaccia F; Lapice E; Martedì E; Memoli G; Oliva D; Romano G; Cittadini A; Zito GB; Oliviero U
Intern Emerg Med; 2021 Jun; 16(4):895-903. PubMed ID: 33068250
[TBL] [Abstract][Full Text] [Related]
47. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
48. Coronary Flow Reserve Changes after Angiotensin Receptor-Neprilysin Inhibitor Treatment in Heart Failure with Reduced Ejection Fraction.
Karaayvaz EB; Güz G
Acta Cardiol Sin; 2023 Nov; 39(6):871-878. PubMed ID: 38022415
[TBL] [Abstract][Full Text] [Related]
49. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
[TBL] [Abstract][Full Text] [Related]
50. Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis.
Fu S; Xu Z; Lin B; Chen J; Huang Q; Xu Y; Xu A; Chen Y; Tang Y
Front Med (Lausanne); 2021; 8():657067. PubMed ID: 34235161
[No Abstract] [Full Text] [Related]
51. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
52. IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study.
Meessen JMTA; Cesaroni G; Mureddu GF; Boccanelli A; Wienhues-Thelen UH; Kastner P; Ojeda-Fernandez L; Novelli D; Bazzoni G; Mangiavacchi M; Agabiti N; Masson S; Staszewsky L; Latini R;
BMC Cardiovasc Disord; 2021 Jul; 21(1):328. PubMed ID: 34217226
[TBL] [Abstract][Full Text] [Related]
53. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Gaggin HK; Bhardwaj A; Januzzi JL
J Cardiovasc Transl Res; 2014 Mar; 7(2):250-61. PubMed ID: 24309956
[TBL] [Abstract][Full Text] [Related]
54. Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction.
Sabbah MS; Fayyaz AU; de Denus S; Felker GM; Borlaug BA; Dasari S; Carter RE; Redfield MM
Circ Heart Fail; 2020 Aug; 13(8):e006414. PubMed ID: 32809874
[TBL] [Abstract][Full Text] [Related]
55. Proteomic Signatures During Treatment in Different Stages of Heart Failure.
Michelhaugh SA; Camacho A; Ibrahim NE; Gaggin H; D'Alessandro D; Coglianese E; Lewis GD; Januzzi JL
Circ Heart Fail; 2020 Aug; 13(8):e006794. PubMed ID: 32809875
[TBL] [Abstract][Full Text] [Related]
56. Short-Term Effects of Sacubitril
Saengklub N; Pirintr P; Nampimoon T; Kijtawornrat A; Chaiyabutr N
Front Vet Sci; 2021; 8():700230. PubMed ID: 34386539
[No Abstract] [Full Text] [Related]
57. Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial.
Stavrakis S; Elkholey K; Morris L; Niewiadomska M; Asad ZUA; Humphrey MB
J Am Heart Assoc; 2022 Feb; 11(3):e023582. PubMed ID: 35023349
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin receptor-neprilysin inhibitor improves New York Heart Association class and N-terminal-pro B-type natriuretic peptide levels: initial experience in a Singapore single-centre cohort.
Koh N; Goh VJ; Teoh CK; Hon JS; Teo LLY; Lim CP; Sim D
Singapore Med J; 2021 Jul; 62(7):359-361. PubMed ID: 34409482
[No Abstract] [Full Text] [Related]
59. IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease.
Lisowska A; Szyszkowska A; Knapp M; Łapińska M; Kondraciuk M; Kamińska I; Hryszko T; Ptaszyńska-Kopczyńska K; Kamiński K
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204773
[TBL] [Abstract][Full Text] [Related]
60. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.
Liu CT; Xu YW; Guo H; Hong CQ; Huang XY; Luo YH; Yang SH; Chu LY; Li EM; Peng YH
Gut Liver; 2020 Nov; 14(6):727-734. PubMed ID: 31822054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
